GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Total Stockholders Equity

Iran Daru (XTEH:IRDR1) Total Stockholders Equity : IRR0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Total Stockholders Equity?

Iran Daru's Total Stockholders Equity for the quarter that ended in . 20 was IRR0.00 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Iran Daru's Book Value per Share for the quarter that ended in . 20 was IRRN/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Iran Daru's Debt-to-Equity for the quarter that ended in . 20 was .


Iran Daru Total Stockholders Equity Historical Data

The historical data trend for Iran Daru's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Total Stockholders Equity Chart

Iran Daru Annual Data
Trend
Total Stockholders Equity

Iran Daru Semi-Annual Data
Total Stockholders Equity

Iran Daru  (XTEH:IRDR1) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Iran Daru's Book Value per Share for the quarter that ended in . 20 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Iran Daru's Debt-to-Equity for the quarter that ended in . 20 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iran Daru Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Iran Daru's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines